A Pilot Study to Investigate the Role of Thymidylate Synthase as a Marker of Prognosis for Neoadjuvant Chemotherapy in Gastric and Gastro-Oesophageal Junction Adenocarcinoma
Aims and Background. Patients in the United Kingdom with operable gastric and gastro-oesophageal junction (GOJ) tumours receive neoadjuvant chemotherapy. Our aim was to study the expression of thymidylate synthase (TS) enzyme in pre-treatment diagnostic biopsy specimens and investigate its clinical...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | Gastroenterology Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2013/502153 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849692653047775232 |
|---|---|
| author | A. Mirza M. Brown C. McNulty J. Valentine A. Annesley S. Galloway I. Welch C. M. West S. Pritchard |
| author_facet | A. Mirza M. Brown C. McNulty J. Valentine A. Annesley S. Galloway I. Welch C. M. West S. Pritchard |
| author_sort | A. Mirza |
| collection | DOAJ |
| description | Aims and Background. Patients in the United Kingdom with operable gastric and gastro-oesophageal junction (GOJ) tumours receive neoadjuvant chemotherapy. Our aim was to study the expression of thymidylate synthase (TS) enzyme in pre-treatment diagnostic biopsy specimens and investigate its clinical usefulness. Methods. A single-centre study was carried out in 45 patients with gastric and GOJ adenocarcinoma treated with neo-adjuvant chemotherapy according to the MAGIC protocol. TS expression was determined using immunohistochemistry. >10% tumour nuclei expression of TS was used as cut-off for positivity. Results. Forty-one (91%) of the 45 tumours expressed TS. There was no association between TS expression and lymph node status (P = 0.80), histological response (P = 0.30), and recurrence (P = 0.55). On univariate analysis, only N-stage (P = 0.02) and vascular invasion (P = 0.04) were associated with a poor prognosis. Patients with negative tumour TS expression had better outcome than those with positive expression. The overall 5-year survival rate was 100% in the TS negative versus 56% in TS positive group, but the difference was not statistically significant (P = 0.17). Conclusion. TS expression should be studied in a larger series of gastro-oesophageal cancers as a potential prognostic marker of prognosis to neo-adjuvant chemotherapy. |
| format | Article |
| id | doaj-art-ea152d8f0e5943f5950f62d7d261cad1 |
| institution | DOAJ |
| issn | 1687-6121 1687-630X |
| language | English |
| publishDate | 2013-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Gastroenterology Research and Practice |
| spelling | doaj-art-ea152d8f0e5943f5950f62d7d261cad12025-08-20T03:20:39ZengWileyGastroenterology Research and Practice1687-61211687-630X2013-01-01201310.1155/2013/502153502153A Pilot Study to Investigate the Role of Thymidylate Synthase as a Marker of Prognosis for Neoadjuvant Chemotherapy in Gastric and Gastro-Oesophageal Junction AdenocarcinomaA. Mirza0M. Brown1C. McNulty2J. Valentine3A. Annesley4S. Galloway5I. Welch6C. M. West7S. Pritchard8Departments of Gastrointestinal Surgery and Histopathology, University Hospital of South Manchester, Manchester M23 9LT, UKDepartments of Gastrointestinal Surgery and Histopathology, University Hospital of South Manchester, Manchester M23 9LT, UKDepartments of Gastrointestinal Surgery and Histopathology, University Hospital of South Manchester, Manchester M23 9LT, UKDepartments of Gastrointestinal Surgery and Histopathology, University Hospital of South Manchester, Manchester M23 9LT, UKDepartments of Gastrointestinal Surgery and Histopathology, University Hospital of South Manchester, Manchester M23 9LT, UKDepartments of Gastrointestinal Surgery and Histopathology, University Hospital of South Manchester, Manchester M23 9LT, UKDepartments of Gastrointestinal Surgery and Histopathology, University Hospital of South Manchester, Manchester M23 9LT, UKTranslational Radiobiology Group, School of Cancer and Enabling Sciences, The University of Manchester, Manchester Academic Health Science Centre, Christie Hospital NHS Trust, Manchester M20 4BX, UKDepartments of Gastrointestinal Surgery and Histopathology, University Hospital of South Manchester, Manchester M23 9LT, UKAims and Background. Patients in the United Kingdom with operable gastric and gastro-oesophageal junction (GOJ) tumours receive neoadjuvant chemotherapy. Our aim was to study the expression of thymidylate synthase (TS) enzyme in pre-treatment diagnostic biopsy specimens and investigate its clinical usefulness. Methods. A single-centre study was carried out in 45 patients with gastric and GOJ adenocarcinoma treated with neo-adjuvant chemotherapy according to the MAGIC protocol. TS expression was determined using immunohistochemistry. >10% tumour nuclei expression of TS was used as cut-off for positivity. Results. Forty-one (91%) of the 45 tumours expressed TS. There was no association between TS expression and lymph node status (P = 0.80), histological response (P = 0.30), and recurrence (P = 0.55). On univariate analysis, only N-stage (P = 0.02) and vascular invasion (P = 0.04) were associated with a poor prognosis. Patients with negative tumour TS expression had better outcome than those with positive expression. The overall 5-year survival rate was 100% in the TS negative versus 56% in TS positive group, but the difference was not statistically significant (P = 0.17). Conclusion. TS expression should be studied in a larger series of gastro-oesophageal cancers as a potential prognostic marker of prognosis to neo-adjuvant chemotherapy.http://dx.doi.org/10.1155/2013/502153 |
| spellingShingle | A. Mirza M. Brown C. McNulty J. Valentine A. Annesley S. Galloway I. Welch C. M. West S. Pritchard A Pilot Study to Investigate the Role of Thymidylate Synthase as a Marker of Prognosis for Neoadjuvant Chemotherapy in Gastric and Gastro-Oesophageal Junction Adenocarcinoma Gastroenterology Research and Practice |
| title | A Pilot Study to Investigate the Role of Thymidylate Synthase as a Marker of Prognosis for Neoadjuvant Chemotherapy in Gastric and Gastro-Oesophageal Junction Adenocarcinoma |
| title_full | A Pilot Study to Investigate the Role of Thymidylate Synthase as a Marker of Prognosis for Neoadjuvant Chemotherapy in Gastric and Gastro-Oesophageal Junction Adenocarcinoma |
| title_fullStr | A Pilot Study to Investigate the Role of Thymidylate Synthase as a Marker of Prognosis for Neoadjuvant Chemotherapy in Gastric and Gastro-Oesophageal Junction Adenocarcinoma |
| title_full_unstemmed | A Pilot Study to Investigate the Role of Thymidylate Synthase as a Marker of Prognosis for Neoadjuvant Chemotherapy in Gastric and Gastro-Oesophageal Junction Adenocarcinoma |
| title_short | A Pilot Study to Investigate the Role of Thymidylate Synthase as a Marker of Prognosis for Neoadjuvant Chemotherapy in Gastric and Gastro-Oesophageal Junction Adenocarcinoma |
| title_sort | pilot study to investigate the role of thymidylate synthase as a marker of prognosis for neoadjuvant chemotherapy in gastric and gastro oesophageal junction adenocarcinoma |
| url | http://dx.doi.org/10.1155/2013/502153 |
| work_keys_str_mv | AT amirza apilotstudytoinvestigatetheroleofthymidylatesynthaseasamarkerofprognosisforneoadjuvantchemotherapyingastricandgastrooesophagealjunctionadenocarcinoma AT mbrown apilotstudytoinvestigatetheroleofthymidylatesynthaseasamarkerofprognosisforneoadjuvantchemotherapyingastricandgastrooesophagealjunctionadenocarcinoma AT cmcnulty apilotstudytoinvestigatetheroleofthymidylatesynthaseasamarkerofprognosisforneoadjuvantchemotherapyingastricandgastrooesophagealjunctionadenocarcinoma AT jvalentine apilotstudytoinvestigatetheroleofthymidylatesynthaseasamarkerofprognosisforneoadjuvantchemotherapyingastricandgastrooesophagealjunctionadenocarcinoma AT aannesley apilotstudytoinvestigatetheroleofthymidylatesynthaseasamarkerofprognosisforneoadjuvantchemotherapyingastricandgastrooesophagealjunctionadenocarcinoma AT sgalloway apilotstudytoinvestigatetheroleofthymidylatesynthaseasamarkerofprognosisforneoadjuvantchemotherapyingastricandgastrooesophagealjunctionadenocarcinoma AT iwelch apilotstudytoinvestigatetheroleofthymidylatesynthaseasamarkerofprognosisforneoadjuvantchemotherapyingastricandgastrooesophagealjunctionadenocarcinoma AT cmwest apilotstudytoinvestigatetheroleofthymidylatesynthaseasamarkerofprognosisforneoadjuvantchemotherapyingastricandgastrooesophagealjunctionadenocarcinoma AT spritchard apilotstudytoinvestigatetheroleofthymidylatesynthaseasamarkerofprognosisforneoadjuvantchemotherapyingastricandgastrooesophagealjunctionadenocarcinoma AT amirza pilotstudytoinvestigatetheroleofthymidylatesynthaseasamarkerofprognosisforneoadjuvantchemotherapyingastricandgastrooesophagealjunctionadenocarcinoma AT mbrown pilotstudytoinvestigatetheroleofthymidylatesynthaseasamarkerofprognosisforneoadjuvantchemotherapyingastricandgastrooesophagealjunctionadenocarcinoma AT cmcnulty pilotstudytoinvestigatetheroleofthymidylatesynthaseasamarkerofprognosisforneoadjuvantchemotherapyingastricandgastrooesophagealjunctionadenocarcinoma AT jvalentine pilotstudytoinvestigatetheroleofthymidylatesynthaseasamarkerofprognosisforneoadjuvantchemotherapyingastricandgastrooesophagealjunctionadenocarcinoma AT aannesley pilotstudytoinvestigatetheroleofthymidylatesynthaseasamarkerofprognosisforneoadjuvantchemotherapyingastricandgastrooesophagealjunctionadenocarcinoma AT sgalloway pilotstudytoinvestigatetheroleofthymidylatesynthaseasamarkerofprognosisforneoadjuvantchemotherapyingastricandgastrooesophagealjunctionadenocarcinoma AT iwelch pilotstudytoinvestigatetheroleofthymidylatesynthaseasamarkerofprognosisforneoadjuvantchemotherapyingastricandgastrooesophagealjunctionadenocarcinoma AT cmwest pilotstudytoinvestigatetheroleofthymidylatesynthaseasamarkerofprognosisforneoadjuvantchemotherapyingastricandgastrooesophagealjunctionadenocarcinoma AT spritchard pilotstudytoinvestigatetheroleofthymidylatesynthaseasamarkerofprognosisforneoadjuvantchemotherapyingastricandgastrooesophagealjunctionadenocarcinoma |